Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer (NSCLC) is a type of lung cancer that includes several subtypes and is characterized by uncontrolled cell growth in lung tissues. It is the most common form of lung cancer.
We are examining how well different doses of RMC-6291 and RMC-6236 are tolerated by people with advanced KRASG12C-mutated solid tumors. This study aims to gather important safety information about this treatment combination.
Health conditions and diseases that the clinical trial is designed to study and treat.
Non-Small Cell Lung Cancer (NSCLC) is a type of lung cancer that includes several subtypes and is characterized by uncontrolled cell growth in lung tissues. It is the most common form of lung cancer.
Pancreatic Adenocarcinoma is a type of cancer that begins in the pancreas, often leading to symptoms like abdominal pain, weight loss, and jaundice. It is known for being aggressive and difficult to detect early.
Colorectal Cancer refers to cancer that starts in the colon or rectum, often presenting with symptoms such as changes in bowel habits, blood in stool, and abdominal discomfort.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.